34
Yonatan Grad Gillian Lieberman, MD Pneumocystis pneumonia in HIV Yonatan Grad, HMS IV Gillian Lieberman, MD September 2005

Pneumocystis pneumonia in HIV

  • Upload
    tranque

  • View
    240

  • Download
    6

Embed Size (px)

Citation preview

Page 1: Pneumocystis pneumonia in HIV

Yonatan GradGillian Lieberman, MD

Pneumocystis pneumonia in HIV

Yonatan Grad, HMS IVGillian Lieberman, MD

September 2005

Page 2: Pneumocystis pneumonia in HIV

Yonatan GradGillian Lieberman, MD

Outline

• Patient presentation

• Overview of PCP

• Gallery of PCP chest radiographs

Page 3: Pneumocystis pneumonia in HIV

Yonatan GradGillian Lieberman, MD

Patient presentation: HPI

• 39 y.o. male with recent HIV diagnosis presents with a two week history of fevers to 102.5F, drenching night sweats, cough sometimes productive of clear sputum, increasing dyspnea on exertion

• Due to profound weight loss and malaise, HIV tested by primary care physician ~6 weeks prior to admission HIV +

• Was scheduled to have appt with ID, but came in a few days early due to fevers and worsening malaise

• Patient admitted for further workup and care

Page 4: Pneumocystis pneumonia in HIV

Yonatan GradGillian Lieberman, MD

Patient presentation: PMH and SH

• HIV PMH:– CD4/Viral load: CD4 = 15, VL > 750,000– Not on HAART, no opportunistic infection

prophylaxis– No known history of OIs, zoster, bacterial PNA– PPD/TB Hx: No PPD, no TB exposures– Hep B, C negative

• Social History:– Non-smoker, no IVDU– MSM, multiple new partners over the past year, no

history of STDs

Page 5: Pneumocystis pneumonia in HIV

Yonatan GradGillian Lieberman, MD

Patient presentation: physical exam & labs

• T 100.1 BP 123/62 P 90 RR 20 O2 Sat 100% RA– With walking, pulse to 120s, desats to 95%

• Derm: tinea cruris• HEENT: thrush, oral hairy leukoplakia; disc margins sharp• Pulm: Clear to auscultation bilaterally• Neuro: AOx3, CN II-XII intact, no peripheral neuropathy

• LDH: 305 (110 - 210)• ABG: pH 7.46 PO2 85 PCO2 27

Page 6: Pneumocystis pneumonia in HIV

Yonatan GradGillian Lieberman, MD

Patient presentation: CXR

CXR read as normal.

However, low lung volumes make it difficult to evaluate right hilar enlargement, diffuse reticular opacities.

Note the metallic objects bilaterally.

Image from AMICAS system, MGH

Requisition: SOB, Pls assess for PNA, infiltrate

Page 7: Pneumocystis pneumonia in HIV

Yonatan GradGillian Lieberman, MD

Patient presentation: CXR

Image from AMICAS system, MGH

Lateral CXR again read as normal.

Lateral view also offers likely identification of metallic objects.

Page 8: Pneumocystis pneumonia in HIV

Yonatan GradGillian Lieberman, MD

Differential diagnosis of normal CXR in AIDS

• Normal• Pneumocystis• M. tuberculosis• Cryptococcus neoformans

Page 9: Pneumocystis pneumonia in HIV

Yonatan GradGillian Lieberman, MD

Respiratory illnesses by CD4 count

CD4 cell count(cells/mm3)

Respiratory illnesses

<500 Recurrent bacterial pneumoniaNon-TB mycobacteria

<200 PCPCryptococcus neoformansBacterial PNA--> bacteremia/sepsisTB-->extrapulmonary, disseminated

<100 Staphylococcus aureusPseudomonas aeruginosaKaposi's sarcomaToxoplasma gondii

<50 Endemic fungi (Histoplasma capsulatum, Coccidiodes immitis)Nonendemic fungi (Aspergillus, Candida)CMVMAC

In HIV, opportunistic respiratory illnesses are indexed by CD4 count.Diseases become more prevalent as CD4 count declines.

Page 10: Pneumocystis pneumonia in HIV

Yonatan GradGillian Lieberman, MD

Respiratory illnesses by CD4 count

Any CD4 count:Upper resp tract infectionObstructive airway diseaseAcute bronchitisBacterial pneumoniaTuberculosisNon-Hodgkin’s lymphomaPulmonary embolusBronchogenic carcinoma

Respiratory illnesses found in HIV- and HIV+ hosts are more prevalent at all CD4 counts, again with increasing

prevalence as CD4 count declines.

Page 11: Pneumocystis pneumonia in HIV

Yonatan GradGillian Lieberman, MD

Multiple patchy ground glass

opacities

Helical CT with IV contrast

Image from AMICAS system, MGH

Page 12: Pneumocystis pneumonia in HIV

Yonatan GradGillian Lieberman, MD

Multiple patchy ground glass

opacities

Helical CT with IV contrast

Image from AMICAS system, MGH

Page 13: Pneumocystis pneumonia in HIV

Yonatan GradGillian Lieberman, MD

Multiple patchy ground glass

opacities

Helical CT with IV contrast

Image from AMICAS system, MGH

Page 14: Pneumocystis pneumonia in HIV

Yonatan GradGillian Lieberman, MD

Multiple patchy ground glass

opacities

Image from AMICAS system, MGH

Helical CT with IV contrast

Page 15: Pneumocystis pneumonia in HIV

Yonatan GradGillian Lieberman, MD

2.1cm enlargedlymph node

Multiple patchy ground glass

opacities

Image from AMICAS system, MGH

Helical CT with IV contrast

Page 16: Pneumocystis pneumonia in HIV

Yonatan GradGillian Lieberman, MD

Atelectasis

Multiple patchy ground glass

opacities

Image from AMICAS system, MGH

Helical CT with IV contrast

Page 17: Pneumocystis pneumonia in HIV

Yonatan GradGillian Lieberman, MD

Ground glass opacities

• Definition: increased attenuation of the lung parenchyma without obscuring pulmonary vascular markings on CT images

• May be the result of a wide variety of interstitial and alveolar diseases

• In immunocompromised, differential:– PCP (most common)– CMV, HSV, RSV bronchiolitis

Page 18: Pneumocystis pneumonia in HIV

Yonatan GradGillian Lieberman, MD

Definitive diagnosis

Can obtain specimens by:• Induced sputum• Bronchoalveolar lavage• Biopsy (rare: cost, risk of pneumothorax)

From http://www.md.huji.ac.il/mirror/webpath/AIDS.html

Pneumocystis jurevici stained with GMS

Requires detection of organisms in respiratory specimens

Induced sputum for our patient was POSITIVE for PCP by immunofluorescence

Page 19: Pneumocystis pneumonia in HIV

Yonatan GradGillian Lieberman, MD

PICC line

Slightly increased density of RLL

Image from AMICAS system, MGH

Outpatient: follow up

Page 20: Pneumocystis pneumonia in HIV

Yonatan GradGillian Lieberman, MD

PCP in AIDS

• AIDS defining illness, occurring most frequently in patients with CD4 < 200 cells/ml3

• Most common OI in HIV-infected patients, though decreasing incidence due to PCP prophylaxis and HAART

• Remains leading cause of death in AIDS patients; associated with not receiving or failure to comply with HAART or prophylaxis

Page 21: Pneumocystis pneumonia in HIV

Yonatan GradGillian Lieberman, MD

PCP: what is it?• Pneumocystis jurevici pneumonia

(formerly known as Pneumocystis carinii)

• Originally classified as protozoa by life cycle, but fungus by rRNA, mtDNA

• First cases in humans diagnosed in premature and malnourished children in Europe during WWII

• Ubiquitous, commonly thought to be transmitted early in life by respiratory route Thomas, C. F. et al. N Engl J Med 2004;350:2487-2498

Page 22: Pneumocystis pneumonia in HIV

Yonatan GradGillian Lieberman, MD

PCP: Clinical manifestations

• Nonproductive cough (95%), fever (79-100%), dyspnea (95%)

• Most common adventitial sounds: crackles, rales; normal chest exam in 50%

• Pulse oximetry, often showing desaturation with exercise

• Arterial blood gas: hypoxemia, hypocarbia, increased A-a gradient

• LDH > 220 (93% sensitive, but not specific)

Page 23: Pneumocystis pneumonia in HIV

Yonatan GradGillian Lieberman, MD

PCP: Radiographic manifestations

• CXR:– Normal CXR found in 0-39%– Classic finding is diffuse perihilar infiltrates, with varying

sensitivity of 61-100% and poor specificity of 70% – Less commonly:

• Pneumothorax, lobar/segmental infiltrates, pneumatocoeles, nodules, upper lobe infiltrates in patients receiving aerosolized pentamidine

– Rare:• Pleural effusions, lymphadenopathy

• CT:– Patchy or nodular areas of ground glass opacity (GGO)– On HRCT, GGO has a 100% sensitivity

Page 24: Pneumocystis pneumonia in HIV

Yonatan GradGillian Lieberman, MD

PCP: Therapy

• 21 days of anti-Pneumocystis treatment regimen – TMP-SMX (Oral or IV)

• Adjunct corticosteroids if ABG on room air shows PaO2 < 70 mmHg, A-a gradient > 35 mmHg

• Ongoing trial to evaluate whether to start ART with PCP tx or delay until completion of treatment

Page 25: Pneumocystis pneumonia in HIV

Yonatan GradGillian Lieberman, MD

PCP CXR Gallery

Page 26: Pneumocystis pneumonia in HIV

Yonatan GradGillian Lieberman, MD

Companion Patient #2: Classic PCP CXR

From http://www.vh.org/adult/provider/radiology/ITTR/PneumocysticCarinii/PCPPA.html

Bilateral perihilar interstitial infiltrates

Page 27: Pneumocystis pneumonia in HIV

Yonatan GradGillian Lieberman, MD

Companion Patient #3: Classic PCP CXR

http://www.auntminnie.com/index.asp?sec=ref&sub=thi&pag=inf&itemid=54761

Bilateral perihilar interstitial infiltrates

Page 28: Pneumocystis pneumonia in HIV

Yonatan GradGillian Lieberman, MD

Companion Patient #4: Atypical PCP CXR

http://www.auntminnie.com/index.asp?sec=ref&sub=thi&pag=inf&itemid=54573

LUL consolidation

Page 29: Pneumocystis pneumonia in HIV

Yonatan GradGillian Lieberman, MD

Companion Patient #5: Atypical PCP CXR

http://www.auntminnie.com/index.asp?sec=ref&sub=thi&pag=inf&itemid=54694

Coarse nodular and linear densities

Page 30: Pneumocystis pneumonia in HIV

Yonatan GradGillian Lieberman, MD

Companion Patient #6 and #7: Atypical PCP CXRs

From http://pathhsw5m54.ucsf.edu/cts/unknown14/cysts.html

From PACS, BIDMC

Small and large pneumatocoeles (cysts)

Page 31: Pneumocystis pneumonia in HIV

Yonatan GradGillian Lieberman, MD

Companion Patient #8: Atypical PCP CXR

http://www.auntminnie.com/ScottWilliamsMD2/CHEST/Infect/Parasites/PCP/Images/PCP-ptx/cxr.jpg

Extensive air space consolidation

Right side pneumothorax

Multiple cystic changes

Page 32: Pneumocystis pneumonia in HIV

Yonatan GradGillian Lieberman, MD

Take home points

• Vast majority of PCP cases in patients with CD4 < 200 cells/ml3

• Take HAART and prophylaxis!• Radiological findings:

– Classic CXR: bilateral perihilar interstitial infiltrates – Multiple atypical CXRs, including normal– CT: ground glass opacities

• Should establish definitive diagnosis rather than treating empirically

• Treat with TMP-SMX; if severe, add corticosteroids

Page 33: Pneumocystis pneumonia in HIV

Yonatan GradGillian Lieberman, MD

References• Boiselle, PM, Crans, CA and Kaplan, MA. The Changing Face of

Pneumocystis carinii Pneumonia in AIDS Patients. AJR 1999; 172: 1301-1309.

• Huang, L. Pulmonary manifestations of HIV. HIVInSite: hivinsite.ucsf.edu 1998

• Miller, WT Jr and Shah, RM. Isolated Diffuse Ground-Glass Opacity in Thoracic CT: Causes and Clinical Presentations. AJR. 2005; 184:613- 622

• Sax, PE, Tietjen, PA. Treatment of Pneumocystis carinii (P. jiroveci) infection in HIV-infected patients. www.uptodate.com 2005

• Stover, DE. Approach to the HIV-infected patient with pulmonary symptoms. www.uptodate.com 2005

• Stringer, JR et al. A new name (Pneumocystis jiroveci) for Pneumocystis from humans. EID. 2002; 8: 891-896

• Thomas, CF and Limper, AH. Pneumocystis Pneumonia. N Engl J Med. 2004; 350:2487-2498

• Tietjen, PA. Clinical presentation and diagnosis of Pneumocystis carinii (P. jiroveci) infection in HIV-infected patients. www.uptodate.com 2005

Page 34: Pneumocystis pneumonia in HIV

Yonatan GradGillian Lieberman, MD

Acknowledgements

• Maryellen Sun, MD• Jason Handwerker, MD• Gillian Lieberman, MD• Pamela Lepkowski• Larry Barbaras